Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Editorial
. 2025 Aug;137(4):548-550.
doi: 10.1161/CIRCRESAHA.125.326944. Epub 2025 Jul 31.

Salvaged Signals, Scarred Filters: Podocyte NPRC in Diabetic Kidney Disease

Jocelyn Cervantes  1 , Jenny E Kanter  1
Affiliations
Editorial

Salvaged Signals, Scarred Filters: Podocyte NPRC in Diabetic Kidney Disease

Jocelyn Cervantes et al. Circ Res. 2025 Aug.
No abstract available

Keywords: Editorials; cardiovascular diseases; diabetic nephropathies; metabolic syndrome; natriuretic peptides.

PubMed Disclaimer

Conflict of interest statement

None.

Comment on

References

    1. Rawshani A, Rawshani A, Franzen S, Eliasson B, Svensson AM, Miftaraj M, McGuire DK, Sattar N, Rosengren A, Gudbjornsdottir S. Mortality and Cardiovascular Disease in Type 1 and Type 2 Diabetes. N Engl J Med 2017;376:1407–1418. doi: 10.1056/NEJMoa1608664 - DOI - PubMed
    1. Afkarian M, Katz R, Bansal N, Correa A, Kestenbaum B, Himmelfarb J, de Boer IH, Young B. Diabetes, Kidney Disease, and Cardiovascular Outcomes in the Jackson Heart Study. Clin J Am Soc Nephrol 2016;11:1384–1391. doi: 10.2215/CJN.13111215 - DOI - PMC - PubMed
    1. Ndumele CE, Rangaswami J, Chow SL, Neeland IJ, Tuttle KR, Khan SS, Coresh J, Mathew RO, Baker-Smith CM, Carnethon MR, et al. Cardiovascular-Kidney-Metabolic Health: A Presidential Advisory From the American Heart Association. Circulation. 2023;148:1606–1635. doi: 10.1161/CIR.0000000000001184 - DOI - PubMed
    1. Fox CS, Matsushita K, Woodward M, Bilo HJ, Chalmers J, Heerspink HJ, Lee BJ, Perkins RM, Rossing P, Sairenchi T, et al. Associations of kidney disease measures with mortality and end-stage renal disease in individuals with and without diabetes: a meta-analysis. Lancet. 2012;380:1662–1673. doi: 10.1016/S0140-6736(12)61350-6 - DOI - PMC - PubMed
    1. Neuen BL, Heerspink HJL, Vart P, Claggett BL, Fletcher RA, Arnott C, de Oliveira Costa J, Falster MO, Pearson SA, et al. Estimated Lifetime Cardiovascular, Kidney, and Mortality Benefits of Combination Treatment With SGLT2 Inhibitors, GLP-1 Receptor Agonists, and Nonsteroidal MRA Compared With Conventional Care in Patients With Type 2 Diabetes and Albuminuria. Circulation. 2024;149:450–462. doi: 10.1161/CIRCULATIONAHA.123.067584 - DOI - PubMed

LinkOut - more resources